company background image
300149 logo

ChemPartner PharmaTechLtd SZSE:300149 Stock Report

Last Price

CN¥7.07

Market Cap

CN¥3.8b

7D

-11.7%

1Y

-6.9%

Updated

23 Dec, 2024

Data

Company Financials

ChemPartner PharmaTech Co.,Ltd.

SZSE:300149 Stock Report

Market Cap: CN¥3.8b

300149 Stock Overview

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. More details

300149 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

ChemPartner PharmaTech Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for ChemPartner PharmaTechLtd
Historical stock prices
Current Share PriceCN¥7.07
52 Week HighCN¥9.86
52 Week LowCN¥3.68
Beta0.83
1 Month Change6.80%
3 Month Change31.17%
1 Year Change-6.85%
3 Year Change-48.01%
5 Year Change-46.03%
Change since IPO5.02%

Recent News & Updates

Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?

Dec 10
Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?

ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%

Sep 30
ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%

Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified

Aug 04
Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified

Recent updates

Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?

Dec 10
Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?

ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%

Sep 30
ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%

Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified

Aug 04
Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified

Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Mar 08
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Shareholder Returns

300149CN BiotechsCN Market
7D-11.7%-1.9%-1.2%
1Y-6.9%-16.2%11.8%

Return vs Industry: 300149 exceeded the CN Biotechs industry which returned -16.2% over the past year.

Return vs Market: 300149 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 300149's price volatile compared to industry and market?
300149 volatility
300149 Average Weekly Movement13.2%
Biotechs Industry Average Movement8.8%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 300149's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300149's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20001,916Swee Lian Woowww.cppt.com.cn

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.

ChemPartner PharmaTech Co.,Ltd. Fundamentals Summary

How do ChemPartner PharmaTechLtd's earnings and revenue compare to its market cap?
300149 fundamental statistics
Market capCN¥3.76b
Earnings (TTM)-CN¥938.29m
Revenue (TTM)CN¥1.01b

3.5x

P/S Ratio

-3.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300149 income statement (TTM)
RevenueCN¥1.01b
Cost of RevenueCN¥817.12m
Gross ProfitCN¥193.60m
Other ExpensesCN¥1.13b
Earnings-CN¥938.29m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.89
Gross Margin19.15%
Net Profit Margin-92.83%
Debt/Equity Ratio9.8%

How did 300149 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:43
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChemPartner PharmaTech Co.,Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Qiwei WangChangjiang Securities Co. LTD.
Feifei XuChina Merchants Securities Co. Ltd.
Xiaofeng LiuChina Minzu Securities